Warfarin therapy is underused for stroke prevention in patients with atrial fibrillation. A clearer understanding of warfarin's risk-benefit profile will enable you to prescribe it safely and appropriately.
|Original language||English (US)|
|Number of pages||17|
|State||Published - 2000|
ASJC Scopus subject areas
- Leadership and Management